Truist on Disc Medicine (IRON): 'A Bullish Indicator If We Ever Saw One'
Tweet Send to a Friend
Truist Securities analyst Danielle Brill reiterated a Buy rating and $86.00 price target on Disc Medicine (NASDAQ: IRON).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
